caffeine was administered to six patients with idiopathic parkinsonism in an attempt to potentiate the therapeutic response of bromocriptine , a dopamine ( da ) receptor agonist , by inhibition of phosphodiesterase .
C0030567
idiopathic parkinsonism
C0006230
bromocriptine